Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 67,425 | 0 | 0 | 0 |
| Gross Profit | N/A | 67,425 | N/A | N/A | N/A |
| Operating Expenses | 152,808 | 258,619 | 299,509 | 227,287 | 216,542 |
| Operating Income | -152,808 | -191,194 | -299,509 | -227,287 | -216,542 |
| Other Income | 16,190 | 25,504 | 6,603 | -10,295 | 50,152 |
| Pre-tax Income | -136,618 | -165,690 | -292,906 | -237,582 | -166,390 |
| Income Tax | 442 | 177 | -601 | -469 | -297 |
| Net Income Continuous | -137,060 | -165,867 | -292,305 | -237,113 | -166,093 |
| Minority Interests | N/A | -28 | -114 | -307 | -7,368 |
| Net Income | $-137,060 | $-165,839 | $-292,191 | $-236,806 | $-158,725 |
| EPS Basic Total Ops | -1.91 | -2.33 | -4.47 | -4.48 | -3.72 |
| EPS Basic Continuous Ops | -1.91 | -2.33 | -4.47 | -4.49 | -3.89 |
| EPS Diluted Total Ops | -1.91 | -2.33 | -4.47 | -4.48 | -3.72 |
| EPS Diluted Continuous Ops | -1.91 | -2.33 | -4.47 | -4.49 | -3.89 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.33 | -4.47 | -4.48 | -3.72 |
| EBITDA(a) | $-154,832 | $-194,171 | $-311,277 | $-229,586 | $-215,090 |